Lymphoma patients alive three years after cell therapy treatment
Nearly half of lymphoma patients treated with Yescarta were alive at least three years after… Read More
6 years ago
CAR-T
US approves first gene therapy for cancer
MIAMI: The United States approved the first gene therapy in the nation on Wednesday --… Read More
8 years ago
Novartis says 82 percent of leukemia patients in remission after CAR-T
BASEL, Switzerland: An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form… Read More
9 years ago